|
Saturday, May 01, 2010
2:45 PM - 4:45 PM |
| Session Number: 1605 |
| Challenges in Adolescent Reproductive Health |
| PAS Topic Symposium |
| Vancouver Convention Centre ~ 301-305 |
| |
| Target Audience: Scientists and clinicians, endocrinologists, adolescent medicine, gynecologists, oncologists and practicing pediatricians. |
| |
| Objectives:
- Understand the differential diagnosis and management of menstrual disorders, including hypothalamic-pituitary-gonadal axis dysfunction, anatomical problems, and disorders of hyperandrogenism[br]- Understand the mechanism of action and pros and cons of different forms of female contraceptives including oral birth control pills, gels, spermicides, intrauterine devices and depot preparations[br]- Uunderstand the array of estrogen preparations available for replacement therapy in hypogonadal girls and the effects of route on estrogen effects[br]- Understand options for fertility preservation in young patients with cancer |
| |
| Chair: Judith L. Ross, Jefferson Medical College, Philadelphia, PA |
| |
| Abnormalities in the menstrual cycle (including functional hypothalamic amenorrhea) and the need for contraception are common reasons for medical consultation in adolescent girls. Much progress has been made towards understanding the neuroendocrine mechanisms that regulate this process. This session will provide a systematic approach to the evaluation and management of menstrual disorders and offer a detailed discussion of current contraceptive options. The choices available for contraception, from birth control pills - including triphasic pills and pills containing androgen antagonists (e.g., drosperidone), to mechanical devices and depot implants all have specific pros and cons that must be understood by prescribing providers of young adolescents. In addition, studies on the type, dose and route of administration of estrogen in hypogonadal girls such as those with Turners syndrome that shed light into whether or not there are true differences in effects depending on route of administration, an area of great contemporary importance. Lastly, the progress in oocyte preservation and future prospects for fertility preservation in young women exposed to gonadotoxic therapy will be discussed. |
| |
| - |
Judith L. Ross
Jefferson Medical College, Philadelphia, PA |
| 2:45 PM - |
Menstrual Disorders in Adolescents: Approach to Diagnosis and Treatment
Catherine M. Gordon
Children[apos]s Hospital of Boston, Boston, MA |
| 3:15 PM - |
New Hormonal and Non-Hormonal Contraceptive Options
Paula Hillard
Stanford University School of Medicine, Stanford, CA |
| 3:45 PM - |
Estrogen Therapy in Hypogonadism: Does Type, Route, and Dose Matter?
Nelly Mauras
Nemours Children[apos]s Clinic, Jacksonville, FL |
| 4:15 PM - |
Novel Strategies To Preserve Reproductive Potential in Young Cancer Survivors: From Bench to Bedside
David M. Lee
Doernbecher Children’s Hospital, Portland, OR |
|
| |
| Program developed by the Lawson Wilkins Pediatric Endocrine Society, Society for Adolescent Medicine and the Pediatric Academic Societies |
| |
|
